#IMMUNOVIR aims to structure and develop our R&D partnership with the internationally renowned research center A*STAR Infectious Diseases Labs – A*STAR IDL. This program is structured around three complementary areas of research in the field of respiratory viral infections: (i) the study of immune responses to infections, (ii) the development of innovative diagnostic technologies, and (iii) new anti-infective immunotherapy strategies.
Already supported by the #PHCMERLION program between Université Claude Bernard Lyon 1 and A*STAR Infectious Diseases Labs – A*STAR IDL, the #IMMUNOVIR program will contribute to synergize our expertise in virology and immunology with the aim of strengthening pandemic preparedness.
The “International Ambition” is a funding scheme that aims to support international collaboration in research, innovation and training in areas of excellence identified by the Région Auvergne-Rhône-Alpes. Many thanks to Région Auvergne-Rhône-Alpes and the #DESRI teams for their support and confidence in our international collaborative research projects.
#RESPIVIR France – Canada Université Claude Bernard Lyon 1 Université Laval Centre de recherche du CHU de Québec-Université Laval Inserm #Jointlab Inserm Auvergne-Rhône-Alpes CNRS CIRI Centre International de Recherche en Infectiologie
